Zivo Bioscience, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Zivo Bioscience, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Zivo Bioscience, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 3.32M shares, a 64.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.32M -6.1M -64.8% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 2.79M -6.63M -70.4% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 2.38M +812K +51.7% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 1.74M -7.68M -81.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 9.42M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 9.42M 0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.57M -7.85M -83.3% Dec 31, 2022 10-K 2024-03-15
Q3 2022 9.42M +2.5K +0.03% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 9.42M +351K +3.87% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 9.42M -412M -97.8% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 9.42M +4.26M +82.4% Dec 31, 2021 10-K 2023-03-14
Q3 2021 9.42M -398M -97.7% Sep 30, 2021 10-Q/A 2022-04-21
Q2 2021 9.07M -398M -97.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 421M +17.2M +4.27% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 5.16M -408M -98.8% Dec 31, 2020 10-K 2022-04-22
Q3 2020 407M +49.2M +13.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 407M +65M +19% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 404M +218M +117% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 413M +233M +129% Dec 31, 2019 10-K 2021-02-25
Q3 2019 358M +189M +112% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 342M +181M +113% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 186M +44.9M +31.8% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 180M +38.9M +27.6% Dec 31, 2018 10-K 2020-03-26
Q3 2018 169M +27.6M +19.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 160M +21M +15.1% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 141M +3.84M +2.79% Mar 31, 2018 10-Q 2018-04-23
Q4 2017 141M +4.36M +3.19% Dec 31, 2017 10-K 2019-02-12
Q3 2017 141M +4.29M +3.14% Sep 30, 2017 10-Q 2017-10-19
Q2 2017 139M +6.53M +4.92% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 137M +4.77M +3.6% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 137M +4.59M +3.47% Dec 31, 2016 10-K 2018-02-21
Q3 2016 137M Sep 30, 2016 10-Q 2016-11-14
Q2 2016 133M +1.91M +1.46% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 133M +2.8M +2.16% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 132M +3.38M +2.63% Dec 31, 2015 10-K 2017-03-31
Q2 2015 131M +3.6M +2.83% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 130M +7.01M +5.7% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 129M +11.9M +10.2% Dec 31, 2014 10-K 2016-03-29
Q3 2014 129M +14.9M +13.2% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 127M +19.5M +18.1% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 123M +17.5M +16.6% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 117M +11.5M +11% Dec 31, 2013 10-K 2015-04-06
Q3 2013 114M +10.5M +10.1% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 108M +7.38M +7.34% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 105M +5.3M +5.3% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 105M +5.28M +5.28% Dec 31, 2012 10-K 2014-03-31
Q3 2012 103M +5.39M +5.51% Sep 30, 2012 10-Q/A 2012-11-19
Q2 2012 100M +3.79M +3.92% Jun 30, 2012 10-Q/A 2012-08-31
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100M +7.33M +7.91% Dec 31, 2011 10-K 2013-03-25
Q3 2011 97.8M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 96.6M Jun 30, 2011 10-Q/A 2011-09-13
Q4 2010 92.7M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.